151 related articles for article (PubMed ID: 33176759)
1. Health variations among breast-cancer patients from different disease states: evidence from China.
Yang Q; Yu X; Zhang W
BMC Health Serv Res; 2020 Nov; 20(1):1033. PubMed ID: 33176759
[TBL] [Abstract][Full Text] [Related]
2. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
Yang Q; Yu XX; Zhang W; Li H
Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life (HRQoL) Using EQ-5D-5L: Value Set Derived for Indian Breast Cancer Cohort.
Wadasadawala T; Mohanty SK; Sen S; Khan PK; Pimple S; Mane JV; Sarin R; Gupta S; Parmar V
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1199-1207. PubMed ID: 37116141
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer.
Criscitiello C; Spurden D; Piercy J; Rider A; Williams R; Mitra D; Wild R; Corsaro M; Kurosky SK; Law EH
Clin Ther; 2021 Jul; 43(7):1228-1244.e4. PubMed ID: 34256965
[TBL] [Abstract][Full Text] [Related]
5. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
[TBL] [Abstract][Full Text] [Related]
6. Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population.
Cheung YB; Luo N; Ng R; Lee CF
Health Qual Life Outcomes; 2014 Dec; 12():180. PubMed ID: 25495840
[TBL] [Abstract][Full Text] [Related]
7. Development of Conversion Functions Mapping the FACT-B Total Score to the EQ-5D-5L Utility Value by Three Linking Methods and Comparison with the Ordinary Least Square Method.
Lee CF; Ng R; Luo N; Cheung YB
Appl Health Econ Health Policy; 2018 Oct; 16(5):685-695. PubMed ID: 29943377
[TBL] [Abstract][Full Text] [Related]
8. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
9. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
Liu T; Li S; Wang M; Sun Q; Chen G
Patient; 2020 Oct; 13(5):537-555. PubMed ID: 32382953
[TBL] [Abstract][Full Text] [Related]
10. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
Gray LA; Wailoo AJ; Hernandez Alava M
Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
[TBL] [Abstract][Full Text] [Related]
11. Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N.
Huang D; Peng J; Chen N; Yang Q; Jiang L
Front Public Health; 2023; 11():1076879. PubMed ID: 36908441
[TBL] [Abstract][Full Text] [Related]
12. Measurement of Health-Related Quality of Life in Individuals With Rare Diseases in China: Nation-Wide Online Survey.
Xu RH; Ng SSM; Luo N; Dong D; Zhang S
JMIR Public Health Surveill; 2023 Oct; 9():e50147. PubMed ID: 37906229
[TBL] [Abstract][Full Text] [Related]
13. Evaluating health-related quality of life in gastric cancer patients in Suzhou, China.
Zhang FF; Ye L; Yin N; Xiong F; Zhao CH; Zhu YB
Ann Palliat Med; 2021 Jul; 10(7):8024-8033. PubMed ID: 34353087
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients.
Lee CF; Luo N; Ng R; Wong NS; Yap YS; Lo SK; Chia WK; Yee A; Krishna L; Wong C; Goh C; Cheung YB
Qual Life Res; 2013 Sep; 22(7):1745-51. PubMed ID: 23054499
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
16. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.
Jiang L; Zhou H; Yang Q; Luo X; Huang D
Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and utility scores of patients with breast neoplasms in China: A multicenter cross-sectional survey.
Wang L; Shi JF; Zhu J; Huang HY; Bai YN; Liu GX; Liao XZ; Mao AY; Ren JS; Sun XJ; Guo LW; Fang Y; Zhou Q; Ma HM; Xing XJ; Zhu L; Song BB; Du LB; Mai L; Liu YQ; Ren Y; Lan L; Zhou JY; Qi X; Sun XH; Lou PA; Wu SL; Li N; Zhang K; He J; Dai M;
Breast; 2018 Jun; 39():53-62. PubMed ID: 29597131
[TBL] [Abstract][Full Text] [Related]
18. Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
Luo N; Cheung YB; Ng R; Lee CF
Health Qual Life Outcomes; 2015 Oct; 13():166. PubMed ID: 26438167
[TBL] [Abstract][Full Text] [Related]
19. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
Su J; Liu T; Li S; Zhao Y; Kuang Y
J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
[No Abstract] [Full Text] [Related]
20. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
